Reported Apr 27, 2022 · Ongoing
Flowflex SARS-CoV-2 Antigen Rapid Test (Self-Testing), CE marked
Acon Biotech (Hangzhou) Co., Ltd.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Acon Biotech (Hangzhou) Co., Ltd. · 398 Tianmushan Road · Hangzhou · N/A
Is this the product you have?
- Flowflex SARS-CoV-2 Antigen Rapid Test (Self-Testing), CE marked
- Lot codes and dates
- Lots
COV1080201COV1105014
- Lots
- Amount recalled
- 303,760
Where it was sold
Why it was recalled
Non-EUA authorized, CE marked, SARS-CoV-2 antigen rapid test kits are being recalled from the U.S. market because use may lead to inaccurate test results, including false negative or false positive test results.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Acon Biotech (Hangzhou) Co., Ltd. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.